Griffith (R-VA), Raskin (D-MD), Jackson Lee (D-TX) - Amendment No. 1 - Incorporates an inter-agency agreement transmitted to Congress by the Office of National Drug Control Policy (ONDCP), the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Justice (DOJ). Specifically, the amendment clarifies when the Attorney General can temporarily and permanently schedule a drug or substance to the newly created schedule A and prevents the Attorney General from permanently scheduling that drug or substance if the Secretary of HHS determines that there is not sufficient potential for abuse. The amendment also clarifies under what circumstances an applicant for a schedule A registration may continue to conduct research with such schedule A substance while their application is pending, among their research accommodations.
Adopted Voice
Y ✓
N
Jackson Lee (D-TX) - Amendment No. 2 - Strikes sentencing commission provision.
Adopted Voice
Y ✓
N
Maloney, Sean (D-NY) - Amendment No. 3 - Requires the Drug Enforcement Administration to make available a report on controlled substance analogues sold by means of the internet.
Adopted Voice
Y ✓
N
Thornberry (R-TX) - Amendment No. 4 - Specifies the factors to determine whether a controlled substance analogue is intended for human consumption, thus making it easier for law enforcement and health officials to take action against synthetic drug manufacturers, distributors, and sellers.
Print